Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes Mellitus: full-pipeline trial registry
49 of 210 indexed Diabetes Mellitus trials are currently recruiting.
Corpus placement: #44 of 28,707 conditions by registered trial count.
210 US clinical trials · 49 currently recruiting · #44 of 28,707 conditions by registered trial count
Diabetes Mellitus: 210 US clinical trials tracked, 49 recruiting.
Diabetes Mellitus is the subject of 210 registered US clinical trials on ClinicalTrials.gov, 49 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 32 in Phase 1-2 (earlier-stage). The most active sponsor is Takeda, running 8 of these trials.
Enrollment posture brief
Registry condition diabetes-mellitus
OPEN 49 | RECR 23% | LATE 26 | EARLY 32 | RANK #44 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Alzheimers Disease (23% recruiting · 150 trials)
Diabetes Mellitus lists 49 open slots (23% of 210 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes Mellitus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes Mellitus is recruiting below its size-band peers.
49 of 210 indexed trials (23.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes Mellitus trials is spread across many organizations.
Takeda accounts for 8 of 210 trials (3.8%). 123 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes Mellitus enrolment sits around 136 participants.
Median target enrolment is 136 among the 209 trials that report a genuine target (sentinel values excluded). 86 of those (41.1%) plan for fewer than 100 participants.
-
Diabetes Mellitus research is mostly interventional.
175 interventional and 35 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
210 total, page 3 of 5
Potential Risk Factors for Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001368
Unmet Social Needs Study
VA Office of Research and Development
NCT04977583
Improving Medication Adherence in the Alabama Black Belt
Weill Medical College of Cornell University
NCT02274844
Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?
Scranton-Temple Residency Program
NCT00984841
Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes
Minneapolis Veterans Affairs Medical Center
NCT00935441
Treatment of Peripheral Neuropathy in Patients With Diabetes
Eli Lilly and Company
NCT00044421
Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.
Takeda
NCT00286429
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
Takeda
NCT00760344
Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study
Stanford University
NCT02061579
Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography
NYU Langone Health
NCT01419652
Hawaii Patient Reward And Incentives to Support Empowerment
University of Hawaii
NCT02123251
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
Takeda
NCT00672919
MY PALS: A Community-Based Physical Activity Support Program for Older Adults
University of Washington
NCT00132288
Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes
US Department of Veterans Affairs
NCT00119054
A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
National Center for Research Resources (NCRR)
NCT00015626
Improving Aspirin Use in Diabetes: A Cluster Randomized Trial
Northwestern University
NCT00262977
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Eli Lilly and Company
NCT00157339
Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit
Alameda County Medical Center
NCT02386540
POGO® Automatic Blood Glucose Monitoring System Clinical Study
Intuity Medical
NCT02333864
Post Approval Study of the Eversense® Continuous Glucose Monitoring
Senseonics
NCT03908125
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women
National Heart, Lung, and Blood Institute (NHLBI)
NCT00666172
Proactive Diabetes Case Management
US Department of Veterans Affairs
NCT00013208
Veterans Walk for Health Study
US Department of Veterans Affairs
NCT00123435
Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral
Johns Hopkins University
NCT05574699
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
Sanofi
NCT00046501
Pharmacist-led Group Medical Visits to Help With Diabetes Management
VA Office of Research and Development
NCT00554671
Health Promoters and Pharmacists in Diabetes Team Management
University of Illinois at Chicago
NCT01498159
Comprehension of Discharge Instructions for Diabetes Therapy and Hospital Readmission
University of Pittsburgh
NCT03279627
AMG 151 Amgen Protocol Number 20100761
Amgen
NCT01464437
The Impact of Diabetes on REvascularization
Vanderbilt University Medical Center
NCT03085524
CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes
University of Massachusetts, Worcester
NCT01416766
Community Diabetes Education Program Evaluation "Code Evaluation"
The University of Texas Health Science Center, Houston
NCT00151190
Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control
Boston Medical Center
NCT00207207
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
Sinocare
NCT05806554
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Icahn School of Medicine at Mount Sinai
NCT03036254
Internet-based Diabetes Education and Case Management
US Department of Veterans Affairs
NCT00105898
Impaired Wound Healing in Diabetic Foot Ulceration
Beth Israel Deaconess Medical Center
NCT00739323
Conexion: A Localized Information Resource on Diabetes and Depression for a Low-income Hispanic Community
Columbia University
NCT03984929
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Oxurion
NCT04527107
Mindful Stress Reduction in Diabetes Self-management Education for Veterans
VA Office of Research and Development
NCT02928952
Day and Night Closed-loop in Young People With Type 1 Diabetes
Jaeb Center for Health Research
NCT02925299
Interprofessional Training to Improve Diabetes Care: The ReSPECT Trial
US Department of Veterans Affairs
NCT00854594
Family PALS (PArtners in Lifestyle Support)
University of North Carolina, Chapel Hill
NCT01324011
Diabetes Therapy to Improve BMI and Lung Function in CF
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00072904
Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood
Ascensia Diabetes Care
NCT00797563
Comparison of Glycemic Control With Smartphone Application
Icahn School of Medicine at Mount Sinai
NCT05592860
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
Mayo Clinic
NCT00217061
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Treatment Research Institute
NCT02059005
T2D Pilot Study for Patients With Uncontrolled Type 2 Diabetes
Duke University
NCT06988540
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
Yale University
NCT04514523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 19 |
| Phase 3 | 18 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes Mellitus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes Mellitus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes Mellitus page
210 registered trials, 49 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 49 Diabetes Mellitus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Takeda sponsors the most Diabetes Mellitus trials on record, review their full trial history before evaluating a specific study. See Takeda's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Mellitus condition card totals 210 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.